Azenta (AZTA) Expected to Announce Quarterly Earnings on Wednesday

Azenta (NASDAQ:AZTA - Get Free Report) will likely be releasing its earnings data before the market opens on Wednesday, February 5th. Analysts expect Azenta to post earnings of $0.05 per share and revenue of $145.69 million for the quarter. Investors interested in registering for the company's conference call can do so using this link.

Azenta (NASDAQ:AZTA - Get Free Report) last issued its earnings results on Tuesday, November 12th. The company reported $0.18 EPS for the quarter, topping the consensus estimate of $0.10 by $0.08. Azenta had a positive return on equity of 1.03% and a negative net margin of 25.01%. The firm had revenue of $170.00 million during the quarter, compared to the consensus estimate of $169.66 million. During the same quarter in the previous year, the firm earned $0.13 earnings per share. The business's quarterly revenue was down 1.2% on a year-over-year basis. On average, analysts expect Azenta to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Azenta Stock Performance

Shares of AZTA traded up $0.14 during mid-day trading on Friday, reaching $54.05. The company had a trading volume of 551,267 shares, compared to its average volume of 357,290. The company has a market capitalization of $2.47 billion, a price-to-earnings ratio of -18.20 and a beta of 1.47. The company's 50 day simple moving average is $49.96 and its 200 day simple moving average is $49.10. Azenta has a 1-year low of $38.82 and a 1-year high of $67.77.

Analysts Set New Price Targets

AZTA has been the topic of a number of research reports. Needham & Company LLC decreased their target price on shares of Azenta from $69.00 to $55.00 and set a "buy" rating on the stock in a research note on Wednesday, November 13th. Stephens restated an "overweight" rating and set a $60.00 price objective on shares of Azenta in a research report on Thursday, January 2nd. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $61.60.

Insider Transactions at Azenta

In other Azenta news, CFO Herman Cueto sold 712 shares of the firm's stock in a transaction that occurred on Tuesday, November 19th. The shares were sold at an average price of $40.07, for a total transaction of $28,529.84. Following the completion of the transaction, the chief financial officer now owns 23,892 shares in the company, valued at approximately $957,352.44. This trade represents a 2.89 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director William L. Cornog purchased 12,500 shares of the company's stock in a transaction dated Monday, November 18th. The stock was purchased at an average price of $39.60 per share, for a total transaction of $495,000.00. Following the transaction, the director now directly owns 14,755 shares in the company, valued at approximately $584,298. This trade represents a 554.32 % increase in their position. The disclosure for this purchase can be found here. Over the last 90 days, insiders have sold 1,423 shares of company stock worth $57,020. Company insiders own 10.62% of the company's stock.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.